HomeArrow IconHomeArrow IconEducationArrow IconIndonesia's MSCI reclassification: what dealmakers need to know

Indonesia's MSCI reclassification: what dealmakers need to know

Ishak Harianto

Ishak Harianto

Account Executive, Ansarada

Indonesia's MSCI reclassification: what dealmakers need to know
MSCI (formerly Morgan Stanley Capital International) has proposed moving Indonesia out of its emerging markets index and into standalone status, with a decision expected by mid-2027. If it goes ahead, it could mean billions of dollars in passive outflows, a wave of compliance-driven share sales and a tougher market for IPOs. Here's what the proposal involves, what I'm hearing from clients, and how dealmakers may want to prepare.

Indonesia may have lost the benefit of the doubt

On 15 October 2026, MSCI said Indonesia's place in its emerging markets index is "no longer appropriate" and opened a consultation on reclassifying it to standalone market status .

For context: MSCI sorts the world's stock markets into developed, emerging and frontier tiers. Trillions of dollars in index funds and ETFs track these indexes, so a market's tier can shape how much global capital flows into its listed companies. Frontier markets are smaller, less liquid markets a step below emerging. Standalone markets sit outside these tiers altogether and aren't part of MSCI's main regional or global indexes. In practice, that could mean funds tracking MSCI's emerging markets index may need to sell their Indonesian holdings, while many funds may not be able to buy back in.

The market's answer came the day after the announcement. The Jakarta Composite Index, Indonesia's benchmark share index, fell around 11%, its biggest one-day drop in 28 years .

I spend my days with the advisors, investors and corporates doing deals across Indonesia. Here's what I'm seeing since the announcement, and what it could mean for anyone with an Indonesian deal on the table in the next 12 months.

What MSCI is actually proposing

MSCI is proposing to reclassify Indonesia directly from emerging market to standalone status, rather than frontier status. The TRADE reports that market feedback suggested a frontier downgrade "would not fully recognise the depth of the market's issues".

The concerns aren't new. MSCI points to "persistent opacity in shareholding structures and suspected coordinated trading behavior", and says it has seen a "lack of evidence of meaningful enforcement".

This has been building throughout the year:

Date What happened
28 Jan 2026 MSCI flags investability concerns and gives Indonesia until May to show progress. The index falls more than 8% in two days (Asia Asset Management)
9 Feb 2026 Indonesia's Financial Services Authority (OJK), stock exchange (IDX) and central securities depository (KSEI) announce reforms, including lifting the minimum free float (the share of a company's stock available for public trading) from 7.5% to 15% (OJK)
2 Apr 2026 IDX publishes its first high shareholding concentration (HSC) notices, flagging listed companies where a small group of shareholders holds most of the shares (FMT/Bloomberg)
23 Jun 2026 MSCI keeps Indonesia as emerging but calls the reforms only "a step in the right direction" and pushes review to November (The Jakarta Post)
15 Oct 2026 MSCI opens the standalone consultation
30 Apr 2027 Consultation feedback closes
By 30 Jun 2027 MSCI decision

In the meantime, MSCI has frozen index changes that would add weight to Indonesian stocks, says it will continue to delete companies flagged under the HSC (high shareholding concentration) framework, and will use data on shareholders with stakes of 1% or more to cut free float estimates. A lower free float estimate typically means a smaller index weighting, and less buying from funds that track the index.

Critically, it "expects to proceed" with the downgrade unless the consultation shows "clear evidence of material improvements". That suggests a downgrade may now be the default outcome, rather than a reprieve.

What I'm seeing on the ground

The headline numbers are stark. The index is down more than 40% this year, Moody's and Fitch have cut Indonesia's sovereign credit outlook to negative, signalling a possible future rating downgrade, and the rupiah has lost around 8% . Back in January, Goldman Sachs and CGS International estimated potential passive outflows (money that index-tracking funds may need to withdraw) at US$7.8 billion and US$8-9 billion respectively – and that was for a downgrade to frontier.

In conversations with clients, three things stand out.

  1. Valuation gaps appear to be widening.
  2. Foreign buyers seem to be asking harder questions earlier.
  3. Private deals look to be holding up better than public ones, at least for now.

And the wider region isn't standing still. Southeast Asia M&A hit US$50.8 billion in the first half of 2026, according to Mergermarket, up 82% year on year, even as deal counts dipped. Capital still appears to be flowing into the region. The question is how much of it Indonesia can keep.

Facing tougher diligence on an Indonesian deal?

What it could mean for dealmakers

MSCI’s final decision is due by the end of June 2027, but deal teams are already navigating changes to Indonesia’s listing and disclosure requirements..

1. A potential wave of compliance-driven capital markets activity. Lifting minimum free float to 15% affects 267 of the 900-plus listed companies: those that already meet the old 7.5% minimum but sit below 15%. If none delist, IDX estimates around Rp187 trillion (about US$11 billion) of shares would need to come to market . Companies worth Rp5 trillion or more must reach 15% by March 2027 if they're already at 12.5% or above. If they're below 12.5%, they must reach 12.5% by March 2027 and 15% by March 2028. Smaller companies have until March 2029 . That could mean placements, secondary sell-downs and rights issues – potentially into a market that's already under pressure.

2. Take-privates could move up the agenda. Reuters analysis notes that controlling shareholders who can't or won't sell down have a third option: buy back and go private. With valuations depressed, some may find that cheaper than a discounted placement. We could see more tender offers (offers to buy out minority shareholders, typically at a premium) and voluntary delistings modelled, if not executed.

3. Cheaper assets, but a higher bar for diligence. Lower public valuations could reset the benchmark for private deals too. That could be an opening for well-capitalised buyers. But when the issue is ownership opacity, buyers are likely to want more certainty on who really owns and controls a target before they sign. The IDX has also just widened its HSC screening , lifting the number of flagged stocks to 383.

4. The IPO window may narrow. With an index freeze in place and standalone status on the table, a listing in Jakarta could be a harder sell to global investors. Sponsors may lean on trade sales, secondary buyouts or offshore listings for exits instead.

5. Domestic capital could matter more. The limit on equity investments by insurers and pension funds is set to rise from 8% to 20%, and Danantara, Indonesia's sovereign wealth fund, has said it will put about half of its US$14 billion 2026 investment budget into listed markets . Local institutions could become the anchor buyers for both placements and private deals.

The bottom line

Indonesia's fundamentals haven't changed overnight. The demographics, the resources and the infrastructure pipeline are all still there. What may have changed is the price of trust.

The dealmakers best placed over the next year are likely to be those who can show buyers exactly what they're getting, and prove it. If you're working through what this means for a live or upcoming deal, let’s talk .

Disclaimer: Data is accurate as at the date of publication and may have changed since. This article is for general information only and does not constitute financial, investment or legal advice.

Bringing order to total transaction management

Confidently control the outcome from the outset in M&A, divestments, capital raising, restructures and more.

Ishak Harianto

Ishak Harianto

Account Executive, Ansarada

Ishak is an Account Executive at Ansarada, based in Ho Chi Minh City and working with dealmakers across Southeast Asia, including Malaysia and Indonesia. He helps advisors and corporate teams run M&A and capital raising processes more efficiently through Ansarada’s AI virtual data room.

Share